Sexually Dimorphic Increases in Bone Mass Following Tissue-specific Overexpression of Runx1 in Osteoclast Precursors

Martha Elena Díaz-Hernández1,2, Christopher W Kinter1,2, Shana R Watson1,2

  • 1Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia 30329, USA.

Endocrinology
|July 26, 2022
PubMed

Insights

Overexpressing Runx1 in female mice enhanced bone health by delaying osteoclast formation and reducing bone resorption. This study reveals Runx1

Area of Science:

  • Bone Biology and Metabolism
  • Cellular and Molecular Biology
  • Genetics and Genomics

Background:

  • Metabolic bone diseases often stem from excessive osteoclast-mediated bone resorption.
  • The transcription factor Runx1 is implicated as a repressor of osteoclast formation.
  • Previous studies suggest Runx1 inhibits osteoclastogenesis, but its upregulation effects are unknown.

Purpose of the Study:

  • To investigate the skeletal effects of conditional Runx1 overexpression in preosteoclasts.
  • To explore the molecular mechanisms underlying Runx1's role in osteoclastogenesis.
  • To identify potential therapeutic targets for metabolic bone diseases.

Main Methods:

  • Generation of novel Runx1 gain-of-function mice (Rosa26-LSL-Runx1).
  • Crossbreeding with LysM-Cre transgenic mice for conditional overexpression in preosteoclasts.
  • Analysis of bone microarchitecture, biomechanical properties, and transcriptomics.

Main Results:

  • Runx1 overexpression in female mice led to increased trabecular bone indices and improved biomechanical properties.
  • These improvements were associated with delayed osteoclastogenesis and reduced bone resorption.
  • Transcriptomic analysis revealed altered gene expression related to redox signaling, apoptosis, and bone remodeling.

Conclusions:

  • Runx1 exhibits anti-osteoclastogenic activity, confirming its inhibitory role in bone resorption.
  • Runx1 overexpression in females positively impacts bone health through specific molecular pathways.
  • These findings offer new insights into Runx1's therapeutic potential for bone diseases.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.9K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
2.2K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
5.2K